CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($) shares in Millions, $ in Millions		3 Months Ended		6 Months Ended
		Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Net sales		$ 2,081	$ 2,022	$ 4,206	$ 4,265
Type of Revenue [Extensible List]		us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Cost of sales		$ (1,755)	$ (1,638)	$ (3,591)	$ (3,422)
Type of Cost, Good or Service [Extensible List]		us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Gross profit		$ 326	$ 384	$ 614	$ 843
Selling, general and administrative expenses		(112)	(111)	(227)	(219)
Research, development and engineering expenses, net		(112)	(107)	(219)	(213)
Amortization of intangibles		0	(3)	(2)	(5)
Other income (expense), net	[1]	22	0	92	(4)
Operating income		124	164	258	401
Income from equity method investment		1	0	2	2
Interest income		1	2	2	2
Interest expense		(13)	(16)	(26)	(32)
Other non-operating items, net		5	2	1	(4)
Income before income taxes		117	152	237	370
Income tax expense		(38)	(48)	(74)	(108)
Net income		79	105	163	262
Less: Net income attributable to non-controlling interest		0	0	1	1
Net income attributable to controlling interest		$ 79	$ 104	$ 162	$ 261
Net earnings per share - basic	[2]	$ 0.91	$ 1.19	$ 1.86	$ 2.98
Net earnings per share - diluted	[2]	$ 0.91	$ 1.19	$ 1.85	$ 2.98
Weighted average number of shares outstanding, net of treasury shares (in millions)	[3]	87.2	87.4	87.2	87.4
Weighted average number of shares outstanding, assuming dilution and net of treasury shares (in millions)		87.3	87.7	87.4	87.7
Cash dividend per share - declared		$ 0.64	$ 0.62	$ 1.28	$ 0.62
Cash dividend per share – paid		$ 0.64	$ 0.62	$ 1.28	$ 0.62

[1] 1) The three months period ending June 30, 2022, includes a gain of $21 million from a patent litigation settlement. The six months period ending June 30, 2022, includes a gain on sale of property of $80 million in Japan in March 2022 and a gain of $21 million from a patent litigation settlement in June 2022.

[2] Participating share awards with the right to receive dividend equivalents are (under the two-class method) excluded from the earnings per share calculation (see Note 11 to the unaudited condensed consolidated financial statements).

[3] The Company’s unvested RSUs and PSUs, of which some included the right to receive non-forfeitable dividend equivalents, are considered participating securities. Calculations of EPS under the two-class method exclude from the numerator any dividends paid or owed on participating securities and any undistributed earnings considered to be attributable to participating securities. The related participating securities are similarly excluded from the denominator.